Literature DB >> 22658245

Secondary causes of dyslipidemia.

Deepthi Vodnala1, Melvyn Rubenfire, Robert D Brook.   

Abstract

The causes of the lipid disorders in patients referred to specialty clinics for difficult-to-treat dyslipidemias are likely multifactorial. However, the importance of evaluating for secondary causes is unclear. The investigators performed a chart review of new patients referred to the University of Michigan Lipid Clinic from January 2004 to June 2011 (n = 824) to evaluate for the prevalence of several secondary causes of dyslipidemia. In addition to lipoproteins, new patients were assessed for secondary dyslipidemias by a standardized protocol consisting of laboratory testing, a nutritional evaluation, and medical history. These data were evaluated to determine the prevalence of several secondary causes of dyslipidemia. A total of 363 separate factors were identified in the 824 patients that were thought to be potential secondary causes of dyslipidemia. Because some patients (n = 83 [10%]) had multiple conditions, there were 230 (28% of the cohort) with ≥1 potential secondary dyslipidemias. The most common conditions were excessive alcohol intake (n = 82 [10%]), uncontrolled diabetes mellitus (n = 68 [8%]), and overt albuminuria. Although other causes occurred less frequently (each individually found in <5% of patients), altogether they were present in a substantial portion of patients (n = 102 [12%]). In conclusion, nearly 1/3 of patients referred to a specialty clinic had identifiable secondary conditions plausibly contributing to their dyslipidemia. Numerous disorders were identified, with diabetes mellitus and excessive alcohol being the most common. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22658245     DOI: 10.1016/j.amjcard.2012.04.062

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson; Karen M Eddleman; Nicole M Jarrett; Ken LaBresh; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

2.  Hemoglobin to Hematocrit Ratio: The Strongest Predictor of Femoral Head Osteonecrosis in Children With Sickle Cell Disease.

Authors:  Douglas Worrall; Kim Smith-Whitley; Lawrence Wells
Journal:  J Pediatr Orthop       Date:  2016-03       Impact factor: 2.324

3.  Association of high-density lipoprotein cholesterol and periodontitis severity in Chinese elderly: a cross-sectional study.

Authors:  Haihua Zhu; Guanchen Ye; Yanyi Xie; Kangqi Zhu; Fudong Zhu; Qianming Chen
Journal:  Clin Oral Investig       Date:  2022-03-29       Impact factor: 3.606

Review 4.  Improvement initiative in LDL-C management in Saudi Arabia: A call to action.

Authors:  Mirvat Alasnag; Zuhier Awan; Ahmed Al Ghamdi; Hind Al Modaimeigh; Mostafa Al Shemiri
Journal:  Int J Cardiol Heart Vasc       Date:  2020-10-27

5.  Diabetic ketoacidosis presenting with pseudonormoglycemia in a 15-year-old girl with type 1 diabetes mellitus.

Authors:  Sinem Akbay; Arda Yel; Ülkü Yıldırımer; Şule Can; Bumin Dündar
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013

Review 6.  Atherosclerotic Cardiovascular Disease Risk and Evidence-based Management of Cholesterol.

Authors:  Satyajeet Roy
Journal:  N Am J Med Sci       Date:  2014-05

Review 7.  Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy.

Authors:  Nicola Tarantino; Francesco Santoro; Luisa De Gennaro; Michele Correale; Francesca Guastafierro; Antonio Gaglione; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Vasc Health Risk Manag       Date:  2017-02-16

8.  Associations between lipid profiles of adolescents and their mothers based on a nationwide health and nutrition survey in South Korea.

Authors:  Ji Hyung Nam; Jaeyong Shin; Sung-In Jang; Ji Hyun Kim; Kyu-Tae Han; Jun Kyu Lee; Yun Jeong Lim; Eun-Cheol Park
Journal:  BMJ Open       Date:  2019-03-20       Impact factor: 2.692

9.  Hypertriglyceridemia and Other Plasma Lipid Profile Abnormalities among People Living with Diabetes Mellitus in Ethiopia: A Systematic Review and Meta-Analysis.

Authors:  Baye Dagnew; Yigizie Yeshaw; Demeke Geremew; Dessie Abebaw Angaw; Henok Dagne; Mekuriaw Alemayehu; Meseret Derbew Molla; Yonas Akalu
Journal:  Biomed Res Int       Date:  2021-05-10       Impact factor: 3.411

10.  Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study.

Authors:  Maya S Safarova; Hongfang Liu; Iftikhar J Kullo
Journal:  J Clin Lipidol       Date:  2016-08-06       Impact factor: 5.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.